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Lung pathogenesisyme 2 (ACE2) is the receptor that severe acute respiratory syndrome coronavirus
(SARS-CoV) utilizes for target cell entry and, therefore, plays an important role in SARS pathogenesis. Since
Chinese rhesus (rh) macaques do not usually develop SARS after SARS-CoV infection, it has been suggested
that rh-ACE2 probably does not support viral entry efﬁciently. To determine the role of rh-ACE2 in early lung
pathogenesis in vivo, we studied eleven Chinese rhesus monkeys experimentally infected with a pathogenic
SARS-CoVPUMC01 strain. Rh-ACE2 genes were ampliﬁed from all animals by reverse transcription polymerase
chain reaction, and their function was studied in vitro using a pseudovirus entry assay. Many natural non-
synonymous (NS) changes were found in rh-ACE2 genes. Compared to human (hu) ACE2, thirty-eight
consensus NS changes were found in rh-ACE2. Since these changes do not interact with the receptor binding
domain of SARS-CoV, rh-ACE2 in general is as effective as human homolog in supporting viral entry. Rh-ACE2,
however, is more polymorphic than hu-ACE2. Additional sporadic NS substitutions in clone Rh11-7 reduced
the level of rh-ACE2 protein expression and did not support viral entry effectively. Further mutagenesis
analysis showed that a natural mutation Y217N dramatically alters ACE2 expression and entry efﬁciency.
Moreover, introduction of the Y217N mutation into hu-ACE2 caused the down-regulation of expression and
reduced viral entry efﬁciency. These results indicate that the Y217N mutation plays a role in modulating
SARS-CoV infection. Our results provide insights for understanding the role of rh-ACE2 in SARS lung
pathogenesis in a non-human primate model.
© 2008 Elsevier Inc. All rights reserved.Introduction
Severe acute respiratory syndrome (SARS), characterized by pul-
monary inﬂammation and respiratory failure, is an emerging infectious
disease causedbya novel coronavirus (CoV) variant, SARS-CoV (Drosten
et al., 2003; Kuiken et al., 2003; Peiris et al., 2003a, 2003b). SARS-CoV is
highly transmissible in humans with a fatality rate near 10% (Donnelly
et al., 2004; Riley et al., 2003). Once infectedwith SARS-CoV, the typical
pathology is severe diffuse alveolar damage (DAD) in patients' lungs,
which leads to the failure of lung function (Hamming et al., 2004;
Mossel et al., 2005; Nicholls et al., 2003; Tse et al., 2004). Soon after
SARS-CoV was isolated, angiotensin-converting enzyme 2 (ACE2) was
identiﬁed as the primary receptor for SARS-CoV (Li et al., 2003). A
recent study of the ACE2 crystal structure revealed that several amino
acid residues are very important for binding to the Spike (S)at AIDS Institute, Li Ka Shing
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l rights reserved.glycoprotein of SARS-CoV (Li et al., 2005b, 2006). Interestingly,
individual or an E145/N147/D157 triple mutant in hu-ACE2 had a pro-
found effect on viral entry, which suggested a critical role for ACE2 in
SARS-CoV pathogenesis (Han et al., 2006; Hofmann et al., 2006; Li et al.,
2005c).
ACE2 was initially identiﬁed as an important component of the
renin angiotensin system,which controls blood pressure and regulates
cardiac function (Crackower et al., 2002). A recent study indicates that
ACE2 knockoutmice exhibit severe pathologywith endotoxin-induced
adult respiratory distress syndrome (ARDS) as compared to ACE2 naive
mice (Imai et al., 2005). The loss of ACE2 expression in knockout mice
results in enhanced vascular permeability, increased lung edema,
neutrophil accumulation and weakened lung function. These results
indicate that ACE2 plays a protective role in ARDS-related lung
damage. Although two studies showed that ACE2 genepolymorphisms
do not seem to affect the outcomeof SARS in humans (Chiu et al., 2004;
Itoyama et al., 2005), a recent small animal study suggests that the
down-regulation of ACE2 could contribute to lung damage in a SARS-
CoV challenge model (Kuba et al., 2005). Up to now, however, it is still
unclear whether a similar mechanism applies to SARS in humans.
Since SARS-CoV cannot be tested in humans, we sought to deter-
mine the role of nativeACE2 and its variants in lungpathogenesis using
Table 1
Clinical evaluation of eleven Chinese rhesus monkeys infected with SARS-CoVPUMC01
and two uninfected animals
Macaque
no.
Gender Age
(years)
Clinical signs Pathologic
examination
IHCa RT-PCRb
Rh13 Female 2.5 – Normal – –
Rh14 Male 2.5 – Normal – –
Rh1 Female 2.5 Loss of appetite,
Agitated, Aggressive
Mild IP + 7.1×101
Rh6 Male 2.5 Loss of appetite Mild IP + 7.1×101
Rh7 Female 2.5 Loss of appetite Mild IP + +
Rh9 Female 3.0 Loss of appetite Mild IP + 1.6×102
Rh10 Male 2.5 Loss of appetite Mild IP + 1.5×103
Rh12 Male 3.2 – Mild IP + 2.7×102
Rh2 Male 4.0 Loss of appetite Severe IP
with DAD
+ +
Rh3 Female 3.0 Little movement,
Dyspnea
Severe IP
with DAD
+ 4.0×103
Rh4 Male 2.5 Loss of appetite Severe IP
with DAD
+ 1.6×102
Rh8 Male 3.0 Loss of appetite,
Agitated, Aggressive
Severe IP
with DAD
+ 7.1×101
Rh11 Female 2.5 Loss of appetite,
Agitated, Aggressive
Severe IP
with DAD
+ +
IP represents interstitial pneumonia while DAD is diffuse alveolar damage. The infected
monkeys were challenged with 1 ml of 105 TCID50 of SARS-CoVPUMC01 via intranasal
route as previously described (Chen et al., 2005).
a IHC stands for immunohistochemical staining.
b The pharyngeal swap samples were collected at day 5 post infection for the
detection of viral RNA by RT-PCR. Rhesus (Rh) monkeys 13 and 14 are uninfected
controls.
90 Y. Chen et al. / Virology 381 (2008) 89–97a SARS-CoV/Chinese monkey model. This model was initially estab-
lished to investigate the causative agent of SARS and has since played
an essential role for testing new strategies for therapies and vaccines
against SARS-CoV infection (Chen et al., 2005; Li et al., 2005a; Qin et al.,
2005). During these studies, however, we found that ChineseFig.1. Pathological evaluation of lung specimens of Chinese rhesusmonkeys. Necropsy tissue
B and E; Rh11, C and F) animals (Table 1). Data based on H.E. (top panel) and immunohist
Macaque Rh1 represents a mild case of infection with thickened alveolar septa and some mo
extensively broadened alveolar septa, increased monocyte inﬁltration, visible exudation of
fusion of thick septa (C and F). SARS-CoV speciﬁc viral antigens were detected in the lung
detected in the control animals (A and D).macaques often recover from the viral infection spontaneously and,
therefore, never died of SARS. Moreover, the severity of lung damage
varies signiﬁcantly in infected Chinese rhesus monkeys as determined
by pathological analysis. Some monkeys developed severe lung
damage with DAD while others only had mild interstitial pneumonia.
These ﬁndings prompted us to examine whether rh-ACE2 could play a
role in early lung pathogenesis in these animals.
Results
Lung pathology of Chinese rhesus monkeys infected with the pathogenic
SARS-CoVPUMC01
To study the relationship betweenACE2 variation and lung damage,
we ﬁrst evaluated the pathologic changes in eleven Chinese rhesus
monkeys (Rh1–Rh12) experimentally infected with SARS-CoVPUMC01
(Table 1). Two uninfected monkeys (Rh13 and Rh14) were included as
controls. Although infected macaques did not have signiﬁcant clinical
signs other than fever and loss of appetite, it was crucial to determine
whether they had developed any pathological changes in their
respiratory system. For this reason, necropsy specimens collected
from the sacriﬁced macaques were evaluated for pathological abnor-
malities on day 7 post infection. We chose day 7 for sampling because
obvious pathological changes were often found in most infected
animals at this time point (Chen et al., 2005; Li et al., 2005a; Qin et al.,
2005). In general, the major histopathological changes were primarily
found in the lung of infected macaques (Figs. 1B, C, E and F). The
infected animals had acute interstitial pneumonia and bronchopneu-
monia. It was common to see multifocal pulmonary consolidations
characterized by broadened alveolar septa, poorly preserved alveolar
lining, epithelial hyperplasia, capillary vessel dilation and congestion,
and interstitial mononuclear inﬂammatory cell inﬁltration. According
to the severity of the pathologic changes, six monkeys (Rh1, 6, 7, 9, 10
and 12) were classiﬁed in the “mild” group (Figs. 1B and E) withsamples were collected from normal (Rh13, A and D) and SARS-CoVPUMC01 infected (Rh1,
ochemical (bottom panel) staining assays are depicted here with 200x magniﬁcation.
nocyte inﬁltration (B and E). Macaque Rh11 represents a severe case of acute DAD with
protein-rich edema ﬂuid in alveolar cavities, ruptured elastic alveolar ﬁbers, and local
of both mild and severe animals. Neither pathological changes nor viral antigens were
Fig. 2. Consensus sequence alignment of human and Chinese rhesus ACE2. Nucleotide sequences of ACE2 cDNAs were derived from animals Rh1–Rh14 by RT-PCR. Rhesus sequences
were compared to seven human homologues in GenBank (accession numbers BC048094, BC039902, AB193260, NM_021804, AB193259, AY358714 and AB046569). Identical amino
acids are indicated by dots whereas differences are shown in uppercase. Critical residues, which likely interact with the RBD of SARS-CoV, are indicated by boxes. Signal sequence,
zinc domain and transmembrane (TM) region are highlighted with solid lines. The arrow indicates the key residue Y217 which is crucial for ACE2 expression and viral entry.
91Y. Chen et al. / Virology 381 (2008) 89–97another ﬁve animals (Rh2, 3, 4, 8 and 11) in the “severe” group (Figs.1C
and F). Animals in the latter group developed acute DAD with
extensively broadened alveolar septa, increasedmonocyte inﬁltration,
visible exudation of protein-rich edema ﬂuid in alveolar cavities,
ruptured elastic ﬁber of alveolus, and local fusion of thick septa
(Figs. 1C and F). In contrast, uninfected animals did not display signs of
lung damage (Figs. 1A and D). SARS-CoV speciﬁc antigens were
detected in both groups of infected animals (Figs. 1E and F).
Natural variation of rh-ACE2 genes among infected monkeys
To understand the role of rh-ACE2 variation in the observed lung
pathology, the genes of rh-ACE2 were ampliﬁed from all animals and
subsequently sequenced. High ﬁdelity Taq-polymerase was used to
minimize the sequence error generated during ampliﬁcation. Based on
the comparison of amino acid sequences, we found that there are 38
differences between the hu- and rh-ACE2, which gave an overall
homology of 91% (Fig. 2 and Table 2). These amino acids are probably
not making direct contacts with the receptor-binding domain (RBD) of
SARS-CoV because they are not the interacting sites previously iden-
tiﬁed (Fig. 2).
Furthermore, there are also 47 sporadic non-synonymous (NS)
variations in rh-ACE2 genes, which are rarely found in hu-ACE2 (Fig. 3).
The G466D mutation was found in half of the animals, but did not
correlate with the severity of lung damage. Sequence analysis showsTable 2
Sequence homology between human and Chinese rhesus ACE2 (%)
Gene Hu-ACE2 Rh-ACE2
Amino acid Nucleotidea Amino acid Nucleotide
Hu-ACE2 99.9 99.9 91.0 96.8
Rh-ACE2 91.0 96.8 99.1 99.7
a Based on Kimura's two-parameter formula. Averages of all pairwise comparisons
for Rh-ACE2: ds=0.0061, dn=0.0023, ds/dn=3.6689, ps/pn=3.6553, while for Hu-ACE2:
ds=0.0060, dn=0.0006, ds/dn=10.4417, ps/pn=10.4043.that hu-ACE2 genes are less diverse with an average intraspecies
genetic homology of 99.9%,which contrasts the 99.1% found in Chinese
monkeys (Table 2). Pairwise comparison indicates that the average ds/
dn of rh-ACE2 (3.6689) is signiﬁcantly smaller than that of hu-ACE2
(10.4417) (Table 2). Multiple ACE2 clones from each animal were
sequenced with consistent variations obtained. Interestingly, none of
these sporadic NS mutations make critical interactions with the RBD
(Figs. 2 and 3). Therefore, the deduced RBD binding residues in ACE2
are highly conserved between human and Chinese rhesus homologues
(Fig. 2). Moreover, the zinc domain which is crucial for the catalytic
activity of ACE2 is also conserved.
Expression of rh-ACE2 in human cells
Since sporadic NS mutations were found in the rh-ACE2 gene of
each animal, we evaluated the expression of these variants in human
cells. After HEK293Tcells were transfectedwith an individual plasmid,
the ACE2 expression was determined using both western blot and
immunoﬂuorescence staining assays. As shown in Fig. 4A, western blot
analysis showed that ACE2 expression of all clones was readily
detectable except for clones 11-7 derived from macaque Rh11 (Fig.
4A). Moreover, the immunoﬂuorescence assay conﬁrmed that there
were a signiﬁcantly lower number of ACE2 expressing cells when
transfected with clone 11-7, which is consistent with the reduced level
of ACE2 expression observed in the Western blot analysis.
Rh-ACE2 supports viral entry
Since there are many NS differences between hu-ACE2 and rh-
ACE2 genes, we sought to determine how efﬁcient rh-ACE2 would
support viral entry. According to the sequence data, we tested every
rh-ACE2 clone that contains unique natural mutations. Five nano-
grams (based on p24) of pseudovirus was used to infect HEK293Tcells
transfected with an individual rh-ACE2 expression plasmid. As shown
in Fig. 4B, all rh-ACE2 variants support viral entry efﬁciently except for
clone 11-7. Interestingly, the level of ACE2 expression was positively
Fig. 3. Sporadic differences between human consensus and individual rhesus ACE2 protein sequence. Identical amino acids are indicated by dots whereas differences are shown in
uppercase. The numbers on top of the alignment stand for the positions of each individual variation in ACE2 protein sequence. Animals are divided into three groups as indicated by
the severity of lung damage (Fig. 1 and Table 1). These variations were conﬁrmed by sequencing at least three molecular clones from each animal. Two rh-ACE2 clones from each
macaque are presented here (e.g. Rh13-1 stands for clone one of rhesus macaque number 13).
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correlation analysis (r=0.62, pb0.01) (Fig. 4C).
Critically, we further compared the levels of rh-ACE2 expression
and viral entry between mild and severe groups of infected animals.
As depicted in Fig. 4D, monkeys with mild lung damage had
relatively higher levels of rh-ACE2 mRNA expression compared to
those in the severe group (t test, pb0.05). Of note, the rh-ACE2
mRNA ratio of Rh11 is 0.05 which is lower than the average value of
the severe group (Fig. 4D). Importantly, rh-ACE2 with consensus NS
differences supports viral entry as efﬁciently as hu-ACE2 (Fig. 4E).
Therefore, rh-ACE proteins except for Rh11-7 serve as an effective
receptor for SARS-CoV entry.
Mutation Y217N reduced the levels of rh-ACE2 expression and viral entry
To identify the key residues which may determine the levels of rh-
ACE2 expression and viral entry, we studied the difference between
pairs of rh-ACE2 genes in each animal. Since there was over 20-fold
difference between clones 11-1 and 11-7 (Fig. 4B), we further
conducted mutagenesis on this pair. By analyzing the proﬁles of all
rh-ACE2 clones in mediating viral entry, we found that there were two
dominant amino acid differences between clones 11-1 and 11-7,
R192G and Y217N (Fig. 5A), which might contribute to the unique
phenotype of 11-7. For this reason, individual amino acid substitutions
(G192R and N217Y) were introduced into clone 11-7. Interestingly, no
signiﬁcant difference was found in ACE2 expression between 11-7 and
11-7(G192R) using western blot and immunoﬂuorescence assays
(Figs. 5B and D). The 11-7(N217Y) mutation, however, was able to
restore the expression of 11-7 approaching the level of 11-1 (Fig. 5B).
This increase is highly signiﬁcant (t test, pb0.01). Accordingly, 11-7
(N217Y) also supported viral entry efﬁciently (Fig. 5C). Therefore, the
natural mutation at position 217 likely plays a critical role in
controlling the levels of rh-ACE2 expression and viral entry.Mutation Y217N affects the levels of hu-ACE2 expression and viral entry
To further determine whether the Y217N mutation would play a
role in hu-ACE2 expression and viral entry, we generated a hu-ACE2
(Y217N) mutant. Similar to the ﬁndings with rh-ACE2 variants, hu-
ACE2(Y217N) displayed signiﬁcantly reduced levels of protein
expression and viral entry (Figs. 6A and B; t test, pb0.05). Therefore,
although the amino acid Y217 does not make a direct contact with
RBD, it is still a critical residue for hu-ACE2 expression and viral
entry.
Discussion
In this study, we characterized the function of ACE2 genes derived
from eleven Chinese rhesus monkeys experimentally infected with
the pathogenic SARS-CoVPUMC01 strain. We found that there are 38
(out of 805, 4.7%) consensus non-synonymous substitutions in rh-
ACE2 when compared with the consensus human homologue. These
substitutions, however, are not involved in viral interaction and,
therefore, do not affect the function of rh-ACE2 in mediating SARS-
CoV S-glycoprotein dependent viral entry. We, however, show that
some sporadic natural non-synonymous mutations are likely critical
for rh-ACE2 expression, which, in turn, affects viral infection signi-
ﬁcantly. In particular, a single amino acid substitution Y217N almost
abolishes rh-ACE2 expression and viral entry. This substitution also
has a similar effect on the function of hu-ACE2. These results indicate
that the natural mutation Y217N in rh-ACE2 probably play a role in
modulating the SARS-CoV infection. Our ﬁndings, therefore, have
implications for understanding the biological function of rh-ACE2, and
the role of its natural mutation in SARS-CoV pathogenesis.
Chinese rhesus monkeys display different proﬁles of lung damage
during the acute phase of infection. The predominant pattern of lung
injury in most acute human cases that end in fatality includes severe
Fig. 4. Natural mutations affect rh-ACE2 expression and viral entry. (A) Rh-ACE2 expression was detected in HEK293T cells transfected with various plasmids by the Western blot
analysis. Theα-tubulinwas used as an internal control. (B) Most rh-ACE2 clones, except for 11-7, supported viral entry into HEK293T cells transfected with corresponding plasmids in
a pseudovirus infection assay. The data were conﬁrmed in two experiments and quadruplicates were tested at each time. Error bars indicate standard deviations. (C) The efﬁciency of
viral entry positively correlated with the level of rh-ACE2 expression with an R value of 0.624 (pb0.01). The level of protein expression was determined by the ratio of OD(ACE2)/OD
(α-Tubulin) using Bandscan Software. (D) As indicated by the asterisk, the average level of rh-ACE2 expression in lung specimens was signiﬁcantly different between themild and the
severe groups (t test, pb0.05). The ratio is based on calculations using the average level of rh-ACE2 expression of normal macaques as a baseline. (E) The average level of viral entry
mediated by consensus rh-ACE2 (clones 8-2 and 8-3 in Fig. 3) is higher than that of hu-ACE2 (t test, pb0.05).
93Y. Chen et al. / Virology 381 (2008) 89–97diffuse alveolar damage (DAD), airspace edema, and bronchiolar ﬁbrin
(Franks et al., 2003). Moreover, some cases also exhibit organizing-
phase DAD, type II pneumocyte hyperplasia, squamous metaplasia,
multinucleated giant cells, and acute bronchopneumonia (Nicholls et
al., 2003; Shieh et al., 2005). In previous studies, it has been reported
that various species of rhesus macaques can be infected by SARS-CoV
(Osterhaus et al., 2004; Qin et al., 2005; Rowe et al., 2004). The
infected animals, however, often recovered from viral infection spon-
taneously and, therefore, never died of SARS. The underlying mecha-
nism which contributes to the disease progression remains unknown
in macaques. In this study, we show that eleven macaques were
successfully infected with SARS-CoVPUMC01, determined mainly by
lung pathology, RT-PCR and immunohistochemical staining assays.
The challenged macaques were sacriﬁced on day seven post infection
so that the acute lung damages were captured for analysis. Consistentwith previous ﬁndings in simian models, SARS-CoV infection indeed
caused DAD, broadening alveolar septa with increased monocyte
inﬁltration, visible exudation in alveolar cavities, ruptured elastic
alveolar ﬁbers, and local fusion of thick septa in Chinese macaques
(Figs. 1C and F) (Li et al., 2005a; Qin et al., 2005). However, only a
portion of infected animals developed “severe” lung damagewith DAD
while others only had “mild” interstitial pneumonia based on patho-
logical evaluations (Table 1 and Fig. 1). This ﬁnding laid the foundation
for further investigation of the function of rh-ACE2 in mediating lung
damage.
The viral entry efﬁciency mediated by rh-ACE2 is unlikely asso-
ciated with the severity of lung damage in infected Chinese rhesus
monkeys. We determine whether the variation of rh-ACE2 plays a
role in SARS lung pathogenesis because ACE2 is the primary receptor
for SARS-CoV entry into target cells. A recent study indicated that
Fig. 5. Inﬂuence of a single natural mutation on rh-ACE2 expression and viral entry. (A) The Y217N mutation is found in seven of nine ACE2 clones of monkey Rh11. The arrows
indicate the major variations in the selected region of rh-ACE2. (B) Various levels of wild type or mutant rh-ACE2 expression were determined by the Western blot analysis. The
positions of rh-ACE2 and α-Tubulin are indicated by arrows. The negative control is HEK293T cells transfected with the pVAX vector alone. Three experiments were conducted with
similar results obtained. (C) The levels of viral entry were determined by a pseudotyped infection assay. The left asterisk indicates a signiﬁcant difference between clones 11-1 and 11-
7 on viral entry (pb0.01). The right asterisk indicates that the N217Y mutation restores the level of viral entry signiﬁcantly as compared to clone 11-7 (t test, pb0.01). Error bars
indicate standard deviations. (D) Various levels of wild type or mutant rh-ACE2 expressionwere determined by an immunoﬂuorescence staining assay using a goat anti-human-ACE2
polyclonal antibody. Original magniﬁcation, ×100.
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derived from nasal or tracheobronchial regions. It was evident that
SARS-CoV may infect the proximal airways and cause highly cytolytic
effects because infected ciliated cells were necrotic and shed over
time onto the luminal surface of the airway (Sims et al., 2005). Since
the ciliated epithelial cells of monkey airway tissues are less
susceptible to infection (Sims et al., 2005), it is possible that rh-Fig. 6. Y217Nmutation reduces the levels of hu-ACE2 expression (A) and viral entry signiﬁcan
The positions of hu-ACE2 and α-Tubulin are indicated by arrows. Three experiments were co
hu-ACE2 and hu-ACE2(Y217N) in mediating viral entry. Error bars indicate standard deviatiACE2 or its variant does not function as an effective receptor for
SARS-CoV, which, in turn, leads to a mild disease outcome (Rowe et
al., 2004). We, however, found that most rh-ACE2 genes supports
viral entry effectively even if they contain 38 or more NS differences
when compared with human counterparts (except for clone 11-7)
(Figs. 2, 3 and 4B). Based on the sequence of Rh8, which harbors
consensus NS differences (Fig. 3), rh-ACE2 supported viral entry withtly (B). (A) The level of rh-ACE2 expressionwas determined by theWestern blot analysis.
nducted with similar results. (B) The asterisk indicates a signiﬁcant difference between
ons.
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therefore believe that, in general, rh-ACE2 itself is not likely acting as a
major restriction factor for the self-limiting infection of SARS-CoV in
macaques. To this end, other factors involved in lung pathology should
be further studied in the model system because previous studies have
demonstrated that multiple factors could have contributed to the lung
damage of infected SARS patients. These factors include the involve-
ment of other host proteins (e.g. L-SIGN), activation of pro-
inﬂammatory cytokines, improper treatment, and manifestations in
multiple organs (Chan et al., 2006; Ding et al., 2004; He et al., 2006;
Huang et al., 2006; Law et al., 2005; Peiris et al., 2004; To et al., 2004).
The natural variation of rh-ACE2 genes is relatively diverse among
Chinese rhesus monkeys. When compared with seven hu-ACE2 genes
deposited in GenBank (Table 2), it is interesting that the sequence
homology among rh-ACE2 genes is smaller than that of hu-ACE2. In
particular, except for Rh8 and Rh10, most animals harbor hetero-
zygous ACE2 genes with distinct NS substitutions (Table 1; Fig. 3).
Moreover, rh-ACE2 has a signiﬁcantly smaller ds/dn ratio than hu-
ACE2 (Table 2). This is unusual compared to monkey chemokine
receptor CCR5 and CXCR4, which are often homozygous genes except
for the heterozygous variants found in some mangabey species (Chen
et al., 1997, 1998a, 1998b). The underlying mechanism driving rh-
ACE2 evolution is, therefore, an interesting area for further
investigation. We report here a Chinese rhesus monkey that harbors
an rh-ACE2 mutant (Rh11-7) which neither expresses well nor
supports viral entry efﬁciently. Since this case was both found among
the “severe” groups, it raises one potential hypothesis that this
variant might arise due to SARS-CoV infection, and the reduced ACE2
expression, in turn, contributes to severe lung damage (Fig. 4D).
Knockdown of ACE2 expression has previously been identiﬁed as a
causative agent for lung damage in a small animal study, lending
further support to this hypothesis (Imai et al., 2005). We found that
infected macaques with severe lung damage had signiﬁcantly lower
levels of ACE2 mRNA when compared to the mild group of animals
(Fig. 4D). This ﬁnding is probably due to the overall damage of lung
tissues, which resulted in the signiﬁcant loss of ACE2 expressing
pneumocytes (Figs. 1C and F), rather than to the emergence of Rh11-7
mutant. Detailed studies may require in vivo monitoring of rh-ACE2
mRNA levels and protein expression in the lung of infected monkeys
over the course of infection, which is technically difﬁcult. Since most
NS variations seem to be sporadic (Fig. 3), there is probably not a
common mechanism for knock down of rh-ACE2 expression in these
animals.
A single, natural mutation in rh-ACE2 gene can determine the
entry efﬁciency of SARS-CoV. A recent structural analysis of hu-ACE2
has identiﬁed the key residues that make direct contact with the
RBD including Q24, T27, K31, H34, E37, D38, Y41, Q42, L45, L79, M82,
Y83, N90, Q325, E329, N330, K353 and G354 (Fig. 2). Interestingly,
these sites are located in three discontinuous regions (i) residues
K31 and Y41 on α-helix 1; (ii) M82, Y83 and P84 on loop 2; and (iii)
K353, D355 and R357 on β-sheet 5 (Li et al., 2005b, 2005c).
Mutagenesis studies further indicate that individual substitution of
these sites or a triple mutant E145/N147/D157A signiﬁcantly reduces
viral infection (Han et al., 2006; Hofmann et al., 2006; Li et al.,
2005c). In this study, since residue Y217 is unlikely to make direct
contact with RBD, it must employ a different mechanism for
reducing viral entry. In this case, the loss of infection is likely due
to the loss of rh-ACE2 expression rather a block of viral interaction
(Figs. 4A and B). Since the introduction of Y217N also has a profound
effect on hu-ACE2 (Figs. 6A and B), the function of the mutation is
unlikely to be a species-speciﬁc phenomenon. We, therefore, believe
that we have identiﬁed a natural mutation, which is likely critical for
a functional domain in regulating the gene expression of both rh-
ACE2 and hu-ACE2. Our results also indicate that natural mutations
in rh-ACE2 probably play a role in modulating SARS-CoV infection
efﬁciency. However, how exactly the Y217N mutation leads to thereduced expression of both rh-ACE2 and hu-ACE2 will require
further investigation.
Materials and methods
Animals
Eleven Chinese macaques were experimentally infected with a
pathogenic strain of SARS-CoV, SARS-CoVPUMC01 as we described in our
previous studies (Chen et al., 2005; Li et al., 2005a; Qin et al., 2005). Tissue
specimens collected on day 7 post infection were used for this study to
understand the early lung pathology. Two uninfected monkeys were
included as controls. The experimentwas conducted inour Bio-safety Level
3 animal facility. Our animal protocols were approved by our institutional
ethic committee before conducting the experiments. The background
information of these animals have been presented in table one.
Pathological evaluation of rhesus specimens
Specimens collected from all seven lung lobes of each infected
animal. The severity of lung damage was determined based on
previously described criteria (Li et al., 2005a). Brieﬂy, the + to ++ in the
six-grade scoring system refer to mild lung damage including alveolar
septa broadening, distorted partially, and mild monocyte inﬁltration
in alveolar septa. The +++ to ++++ refer to severe lung damage
including DAD, extensive alveolar septa broadening, restricted fusion
of thick septa by pressure, ruptured elastic ﬁber of septa, variably ﬁlled
with ﬁbrin, erythrocytes, cellular debris, and enhanced inﬁltration of
inﬂammatory cells in alveolar cavities. For the detection of SARS-CoV
viral antigens, we used an immunohistochemical assay as previously
described (Li et al., 2005a; Qin et al., 2005).
Rh-ACE2 sequence analysis
Total RNA was isolated from lung and kidney tissues using Trizol
(Invitrogen, Carlsbad, CA). cDNAwas generated from 1 μg of total RNA
using the Protoscript First Strand cDNA Synthesis Kit (NEB, Ipswich,
MA) and subjected to PCR to amplify the full-length rhesus ACE2 (Rh-
ACE2) gene by nested PCR with primer pairs: external forward 5′-
GAGGA GGTTT TAGTC TAGGG AAAGT-3′; external backward: 5′-
GAGAA CCTCA CTAAA ACAAC-3′; internal forward:5′-TCGGG GTACC
CAGTG TATGT GATCT TGGCT CA-3′; internal backward: 5′-ACAAA
AAAGA GAACC TCACT TTCCC CCTT-3′). High ﬁdelity Taq polymerase
(Roche, Indianapolis, IN) was used for the reaction. The ampliﬁcation
cycles include: 30 s at 94 °C for 1 cycle; 30 s at 94 °C, 30 s at 58 °C,
2 min and 30 s at 68 °C for 35 cycles, followed by an extension for
10 min at 72 °C using outer primers; then 30 s at 94 °C for 1 cycle; 30 s
at 94 °C, 30 s at 58 °C, 2 min and 30 s at 68 °C for 35 cycles, followed by
an extension for 10min at 72 °C using inner primers. The PCR products
were subsequently cloned and sequence analyzed. GenBank accession
numbers are FJ170076–FJ170101.
Rh-ACE2 mRNA quantiﬁcation using real-time PCR
Onemicrogram total RNA extracted frommonkey's lung tissuewas
subjected to reverse transcription to generate cDNA. Two μl cDNA of
each sample was used to quantify the Rh-ACE2mRNAwith QuantiTect
SYBR Green PCR Master Mix (Qiagen, Valencia, CA) in the Real-time
LightCycler PCR system (Roche, Indianapolis, IN). As a control, 2 μl
cDNA of each sample was also subjected to real-time PCR using
GAPDH-speciﬁc oligonucleotides. The following primer pairs were
used: (i) Rh-ACE2 forward: 5′-GGACC CAGGA AATGT TCAGA-3′ and
backward: 5′-GGCTG CAGAA AGTGA CATGA-3′ (15); (ii) GAPDH gene
forward: 5′-ACAAC TTTGG CATTG TGGAA-3′ and backward: 5′-GATGC
AGGGA TGATG TTCTG-3′. Differences in ACE2 expression were repre-
sented as the fold change in gene expression using the 2−ΔΔCT
96 Y. Chen et al. / Virology 381 (2008) 89–97method. The housekeeping gene GAPDH was used as the internal
control.
Western blot assay
Forty-eight hours post transfection, HEK293T cells were harvested
and lysed in lysis buffer (50mMTris–HCl [pH 8.0],137mMNaCl, 2mM
EDTA, 0.5% NP-40, 10% glycerol, 1 μg/ml each of pepstatin, leupeptin,
and pefabloc). Cell lysates were boiled at 100 °C for 10 min and then
subjected to 10% tris–glycine gel (Invitrogen, Carlsbad, CA). Proteins
were transferred to a PVDF membrane (Invitrogen, Carlsbad, CA) and
incubated with blocking buffer (5% milk and 0.05% BSA) overnight. A
rabbit anti-human ACE2 polyclonal antibody (ab15348; Abcam, Cam-
bridge, UK) was used to detect the expression of ACE2 as previously
described (Chen et al., 2005). The HRP-labeled anti-rabbit IgG
(Amersham-Pharmacia, Piscataway, NJ) was used as the secondary
antibody.
Immunoﬂuorescence assay
HEK293T cells transfected with ACE2 expression plasmids were
washed with PBS and ﬁxed with 100% cold methanol for 10 min at
48 h post transfection. Fixed cells were washed and then incubated
with goat anti-human ACE2 antibody (AF933; R and D systems,
Minneapolis, MN). The positive cells were detected, after a FITC-
conjugated donkey anti-goat IgG (Invitrogen, Carlsbad, CA) staining
step, under a ﬂuorescence microscope.
Pseudovirus entry assay
This assay has been described in our previous publications (Chen
et al., 2005; Liu et al., 2007; Yi et al., 2005). Brieﬂy, HEK293T cells
(1.5×105 cells per well) in 6-well plates were transfected with 1 μg
ACE2 plasmid (SuperFect Transfection Reagent). On the following day,
the transfected cells were diluted to 1.5×105 cells/mL and seeded in
96-well plates in a volume of 100 μl per well at 37 °C overnight.
Forty-eight hours post transfection, 5 ng pseudotyped virus (based on
p24 concentrations) and 16 ng polybrene (in 100 μl medium) were
added to the cells. Seventy-two hours after viral inoculation, cells
were tested for virus-encoded luciferase activity using proper rea-
gents (Promega, Madison, WI) and measured in a DYNEX REVELA-
TION 4.06 machine.
Mutagenesis of Rh-ACE2 and Hu-ACE2 genes
QuickChange® Site-Directed Mutagenesis System (Stratagene, La
Jolla, CA) with PfuUltra™ High-Fidelity DNA polymerase was used to
generate mutations in Rh-ACE2 and Hu-ACE2 genes. The amino acid
change the nucleotide mutation were performed as follows: G192R:
AGA to GGA; N217Y: TAC to AAC. The following primers were used to
generate mutants: (i) 11-7 ACE2 (G192R) Forward: 5′-AAAAA TGAGA
TGGCA AGAGC AAATC ATTATA-3′ and Backward: 5′-TATAA TGATT
TGCTC TTGCC ATCTC ATTTT T-3′, (ii) 11-7 ACE2 (N217Y) Forward: 5′-
GTAGA TGGCT ATGAC TACAA CCGCG ACCAGT-3′ and Backward: 5′-
ACTGG TCGCG GTTGT AGTCA TAGCC ATCTA C-3′. The ampliﬁcation
parameters used were as follows: 30 s at 95 °C for 1 cycle; 30 s at
95 °C, 1 min at 55 °C, 6 min at 68 °C for 15 cycles. We followed the
manufacturer's instruction for the rest of the experiment.
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